Orbital Therapeutics
PrivateLast Round
Series A
Apr 26, 2023
Total Funding Raised
$270M
Company Overview
Orbital Therapeutics is a biotechnology company that develops an innovative RNA therapeutics platform to deliver a comprehensive portfolio of treatments for various human diseases, including vaccines, immunomodulation, protein replacement, and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orbital Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Orbital Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 26, 2023 |
Key People
Founding team and executive leadership
Orbital Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series A |
| Newpath Partners | Series A |
| Agent Capital | Series A |
| DisruptAD | Series A |
| ARCH Venture Partners | Series A |
| Rellim Capital Management | Series A |
| Moore Strategic Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2025
Developing a new RNA platform to create next-generation RNA medicines.
- Sep 8, 2025
Adam Raff appointed Senior Vice President, Clinical Development.
Orbital Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orbital Therapeutics's valuation, stock price, and market status.
